You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is A 70 years old hypeensive patient with stage 5 chronic kidney disease was diagnosed recently with Type 2 diabetes mellitus. He doesn't want to take injectable insulin. Which of the following oral hypoglycemic agents will be preferred in this patient, which won't require any renal dose modification? and explain in detail?
Answer- A. Linagliptinlinagliptin has the ability to be safely dosed in chronic kidney disease patients. Chronic kidney disease is a major complication in type 2 diabetesLinagliptin .No dose required linagliptin for patients with renal impairment